Integrative protocols complement standard treatments, aiming to support quality of life and recovery.
Simarouba quassinoids can stop protein synthesis and cell cycle progression in cells that divide quickly. By stopping signaling cascades that lead to uncontrolled tumor growth, they stop it from happening.
Angiogenesis is what tumors need to get oxygen and nutrients. Researchers are looking into simarouba bioactives to see if they can lower the levels of pro-angiogenic mediators, which would limit the blood supply to cancerous tissues
Chronic inflammation supports the growth of tumors. Quassinoids have regulatory effects on inflammatory signaling pathways, such as changing cytokines and stopping key transcription factors that are linked to activating the tumor microenvironment.
New preclinical research points to the possibility of controlling matrix degradation enzymes and cellular adhesion pathways, which could stop the spread of cancer.
Cancer cells primarily utilize aerobic glycolysis, known as the "Warburg effect," for energy. Researchers are looking into simarouba bioactives to see if they can change glycolytic flux and mitochondrial adaptability, which could make tumors less flexible in their metabolism.
Instead of only affecting one receptor, Simarouba bioactives work on many metabolic and inflammatory pathways. This systems-level approach fits with CELLF's new way of thinking about drug discovery, which focuses on tumor ecology instead of just tumor mass.
β-NMN increases the amount of NAD⁺ inside cells, which helps activate sirtuins, repair DNA, and keep mitochondria working. This is important for metabolic resilience and aging biology.
EGCG, resveratrol, and pterostilbene target NF-κB and oxidative stress pathways, mitigating chronic low-grade inflammation linked to tumor advancement and metabolic impairment.
The combined formulation affects AMPK signaling, mitochondrial efficiency, and glucose metabolism. This helps keep metabolism healthy and may also limit energy pathways that help tumors grow.
Simarouba & Magnolia help reduce inflammation and control cellular signaling, which makes the body more resilient during cancer treatment.
This formulation by CELLF, is meant to help with metabolic health and cell defense, bringing together longevity science and cancer support. Its strength comes not from individual molecules, but from how they work together in a coordinated way.
Bacillus coagulans helps restore good gut flora, increases the production of short-chain fatty acids, and helps keep the epithelial barrier intact, which is very important during chemotherapy-induced dysbiosis.
Mucositis is a common side effect of cancer treatments. Mint bioactives have calming, antimicrobial, and anti-inflammatory effects that help keep the mouth comfortable and the balance of microbes in the mouth.
A balanced microbiome affects the body's immune system. Probiotic stabilization may enhance T-cell regulation and diminish pro-inflammatory cytokine cascades.
Vitamin K2 contributes to cellular signaling pathways linked to tissue repair and immune function.
Dextrase assists digestive efficiency, reducing gastrointestinal burden during treatment cycles
This formulation is positioned as a microbiome-centered adjunct, helping maintain oral and gut ecosystem integrity — especially valuable during chemotherapy, radiation, and recovery phases where mucosal disruption and dysbiosis are common.